Mount Sinai Chelsea ( Site 1760) — New York, New York

Mount Sinai Chelsea ( Site 1760) is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Chelsea ( Site 1760) has participated in 1 clinical trials.

Therapeutic areas: Cervical Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Chelsea ( Site 1760)?

Mount Sinai Chelsea ( Site 1760) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Chelsea ( Site 1760) conducted?

Mount Sinai Chelsea ( Site 1760) has 1 clinical trials on record. Their work covers Cervical Cancer.

Is Mount Sinai Chelsea ( Site 1760) accredited by Crixeo Health?

Mount Sinai Chelsea ( Site 1760) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Chelsea ( Site 1760)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.